Literature DB >> 30023365

Cervical or thoracic anastomosis for patients with cervicothoracic esophageal squamous cell carcinoma.

Ran Mo1, Chen Chen2, Liang Pan1, Ao Yu1,3, Tao Wang1.   

Abstract

BACKGROUND: For cervical and higher-level esophageal tumors, the choice of cervical anastomosis or thoracic anastomosis is still controversial. The goal of this study was to explore the optimal surgical approach for cervicothoracic esophageal squamous tumors.
METHODS: We retrospectively analyzed 3,802 consecutive patients with esophageal squamous cell tumors in Nanjing Drum Tower Hospital from Jan 2001 to Jan 2017. Twenty-six patients with cervical anastomosis and twenty-eight patients with thoracic anastomosis were evaluated.
RESULTS: The cervical anastomosis group exhibited a greater number of resected lymph nodes (36.5±7.3 vs. 19.9±5.7, P<0.001). In addition, the cervical anastomosis group exhibited a higher recurrence rate (71.4% vs. 41.7%, P=0.047) and increased locoregional recurrence (P=0.040). Overall survival was not significantly different between groups (P=0.331). Moreover, multivariate Cox regression analysis revealed that postoperative locoregional recurrence is an independent risk factor for survival (P=0.031, 95% CI: 1.114-8.952).
CONCLUSIONS: Thoracic anastomosis led to satisfactory results in patients with cervicothoracic esophageal squamous tumors.

Entities:  

Keywords:  Esophageal tumor; squamous cell carcinoma; thoracic anastomosis

Year:  2018        PMID: 30023365      PMCID: PMC6035988          DOI: 10.21037/atm.2018.05.19

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  27 in total

Review 1.  Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis.

Authors:  Panagiotis Georgiou; Emile Tan; Nikolaos Gouvas; Anthony Antoniou; Gina Brown; R John Nicholls; Paris Tekkis
Journal:  Lancet Oncol       Date:  2009-09-18       Impact factor: 41.316

2.  Therapeutic value of lymph node dissection for esophageal squamous cell carcinoma after neoadjuvant chemotherapy.

Authors:  Hiroshi Miyata; Makoto Yamasaki; Tomoki Makino; Yasuhiro Miyazaki; Tsuyoshi Takahashi; Yukinori Kurokawa; Kiyokazu Nakajima; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  J Surg Oncol       Date:  2015-07-14       Impact factor: 3.454

Review 3.  Systematic review and meta-analysis of the effectiveness and safety of extended lymphadenectomy in patients with resectable gastric cancer.

Authors:  L Jiang; K H Yang; Y Chen; Q L Guan; P Zhao; J H Tian; Q Wang
Journal:  Br J Surg       Date:  2014-03-25       Impact factor: 6.939

4.  Thoracic recurrent laryngeal lymph node metastases predict cervical node metastases and benefit from three-field dissection in selected patients with thoracic esophageal squamous cell carcinoma.

Authors:  Hecheng Li; Su Yang; Yawei Zhang; Jiaqing Xiang; Haiquan Chen
Journal:  J Surg Oncol       Date:  2011-11-21       Impact factor: 3.454

5.  Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer.

Authors:  Thomas W Rice; Hemant Ishwaran; Mark K Ferguson; Eugene H Blackstone; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2016-10-31       Impact factor: 15.609

6.  Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Authors:  Surya S A Y Biere; Mark I van Berge Henegouwen; Kirsten W Maas; Luigi Bonavina; Camiel Rosman; Josep Roig Garcia; Suzanne S Gisbertz; Jean H G Klinkenbijl; Markus W Hollmann; Elly S M de Lange; H Jaap Bonjer; Donald L van der Peet; Miguel A Cuesta
Journal:  Lancet       Date:  2012-05-01       Impact factor: 79.321

7.  Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.

Authors:  Mitsuo Tachibana; Shoichi Kinugasa; Hiroshi Yoshimura; Muneaki Shibakita; Yasuhito Tonomoto; Dipok Kumar Dhar; Naofumi Nagasue
Journal:  Am J Surg       Date:  2005-01       Impact factor: 2.565

8.  Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy.

Authors:  Alexander W Phillips; Sjoerd M Lagarde; Maziar Navidi; Babbet Disep; S Michael Griffin
Journal:  Ann Surg       Date:  2017-04       Impact factor: 12.969

9.  Cervical, mediastinal, and abdominal lymph node dissection (three-field dissection) for superficial carcinoma of the thoracic esophagus.

Authors:  H Kato; Y Tachimori; S Mizobuchi; H Igaki; A Ochiai
Journal:  Cancer       Date:  1993-11-15       Impact factor: 6.860

10.  Extent of Lymphadenectomy and Prognosis After Esophageal Cancer Surgery.

Authors:  Jesper Lagergren; Fredrik Mattsson; Janine Zylstra; Fuju Chang; James Gossage; Robert Mason; Pernilla Lagergren; Andrew Davies
Journal:  JAMA Surg       Date:  2016-01       Impact factor: 14.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.